Mounjaro 7.5 mg Injection Pen
Mounjaro 7.5 mg Injection Pen
Mounjaro 7.5 mg (tirzepatide) is a once-weekly injectable GLP-1/GIP dual receptor agonist used for Type 2 diabetes management and chronic weight management. The 7.5 mg dose is the third step in the titration schedule, reached after completing 4 weeks each on 2.5 mg and 5 mg — providing stronger appetite suppression and improved glycemic control.
- Dual GIP & GLP-1 Technology: stimulates two satiety hormones together for powerful appetite control
- Progressive Dose: builds on 2.5 mg and 5 mg foundation with increased suppression
- Sustained Weight Loss: clinical trials show significant weight reduction at this dose level
- Precise Blood Sugar Control: stimulates insulin only when blood sugar is elevated
Couldn't load pickup availability
Key Active Ingredient
Key Active Ingredient
Why Choose This Product
Why Choose This Product
When to use ?
When to use ?
Warnings and Precautions
Warnings and Precautions
How to use ?
How to use ?
Information that matters.
Information that matters.
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

